Diagnosing peripheral neuropathy in South‐East Asia: A focus on diabetic neuropathy
Autor: | Charungthai Dejthevaporn, Aimee Andag-Silva, Norlela Sukor, Rizaldy Taslim Pinzon, Manfaluthy Hakim, Rayaz A. Malik, Jasmine S Koh, Ka Sing Wong |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2020 |
Předmět: |
medicine.medical_specialty
Diabetic neuropathy Activities of daily living Peripheral neuropathy Endocrinology Diabetes and Metabolism South‐East Asia 030209 endocrinology & metabolism Chronic inflammatory demyelinating polyneuropathy Review Article Diseases of the endocrine glands. Clinical endocrinology 03 medical and health sciences 0302 clinical medicine Diabetic Neuropathies Diabetes mellitus Internal medicine Diagnosis Internal Medicine Medicine Humans South east asia Review Articles Stabbing Pain Asia Southeastern business.industry Peripheral Nervous System Diseases General Medicine Hepatitis B RC648-665 medicine.disease Prognosis business 030217 neurology & neurosurgery |
Zdroj: | Journal of Diabetes Investigation Journal of Diabetes Investigation, Vol 11, Iss 5, Pp 1097-1103 (2020) |
ISSN: | 2040-1124 2040-1116 |
Popis: | Burning and stabbing pain in the feet and lower limbs can have a significant impact on the activities of daily living, including walking, climbing stairs and sleeping. Peripheral neuropathy in particular is often misdiagnosed or underdiagnosed because of a lack of awareness amongst both patients and physicians. Furthermore, crude screening tools, such as the 10‐g monofilament, only detect advanced neuropathy and a normal test will lead to false reassurance of those with small fiber mediated painful neuropathy. The underestimation of peripheral neuropathy is highly prevalent in the South‐East Asia region due to a lack of consensus guidance on routine screening and diagnostic pathways. Although neuropathy as a result of diabetes is the most common cause in the region, other causes due to infections (human immunodeficiency virus, hepatitis B or C virus), chronic inflammatory demyelinating polyneuropathy, drug‐induced neuropathy (cancer chemotherapy, antiretrovirals and antituberculous drugs) and vitamin deficiencies (vitamin B1, B6, B12, D) should be actively excluded. Diabetic neuropathy has a major impact on morbidity and mortality. However, the diagnosis and management of diabetic neuropathy is South‐East Asia is limited. Clear guidance is required to diagnose and manage patients with diabetic and other neuropathies. |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |